Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies

Letter from Chief Medical Officers encourages participation in COVID-19 trials, including PRINCIPLE

The Chief Medical Officers of England, Wales, Scotland and Northern Ireland, and the NHS Medical Director, have written a letter to all doctors today strongly encouraging participation in the national randomised trials in COVID-19 of which PRINCIPLE is one.

Please read the letter and pass it on to your colleagues.

Similar stories

New study shows ivermectin lacks meaningful benefits in COVID-19 treatment

New research led by the University of Oxford has concluded that the antiparasitic drug ivermectin does not provide clinically meaningful benefits for treating COVID-19 in a largely vaccinated population.

(PRINCIPLE) Platform trial rules out treatments for COVID-19

Findings into colchicine published in the British Journal of General Practice

Findings from research by the PRINCIPLE Trial into treatment of COVID-19 in the community with the anti-inflammatory drug colchicine published in the British Journal of General Practice.

PRINCIPLE Trial calls on UK primary care to support patient recruitment

The Co-Chief Investigators of the PRINCIPLE Trial, Professor Chris Butler and Professor Richard Hobbs, write an open letter to health professionals across UK primary care calling on their support, so those who are still contracting COVID-19 are given the opportunity to join the trial.

PRINCIPLE trial rolled out across UK homes and communities

National priority COVID-19 trial recruits first patients

Researchers from Oxford University are now enrolling participants into PRINCIPLE, the first clinical trial of potential COVID-19 treatments to take place in GP practices.